KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Debt (2016 - 2023)

Medpace Holdings' Total Debt history spans 7 years, with the latest figure at $55.0 million for Q2 2023.

  • For Q2 2023, Total Debt fell 88.99% year-over-year to $55.0 million; the TTM value through Jun 2023 reached $55.0 million, down 88.99%, while the annual FY2022 figure was $50.0 million, N/A changed from the prior year.
  • Total Debt reached $55.0 million in Q2 2023 per MEDP's latest filing, down from $115.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $499.4 million in Q2 2022 to a low of $50.0 million in Q4 2022.
  • Average Total Debt over 3 years is $152.5 million, with a median of $85.4 million recorded in 2019.
  • Peak YoY movement for Total Debt: plummeted 71.77% in 2019, then crashed 88.99% in 2023.
  • A 3-year view of Total Debt shows it stood at $55.8 million in 2019, then decreased by 10.36% to $50.0 million in 2022, then increased by 10.0% to $55.0 million in 2023.
  • Per Business Quant, the three most recent readings for MEDP's Total Debt are $55.0 million (Q2 2023), $115.0 million (Q1 2023), and $50.0 million (Q4 2022).